JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Clinical Pathology 2006;59:345-351; doi:10.1136/jcp.2005.026799
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marouf, R
Right arrow Articles by Al Wazzan, H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marouf, R
Right arrow Articles by Al Wazzan, H

ORIGINAL ARTICLE

Comparison of renal function markers in Kuwaiti patients with sickle cell disease

R Marouf1, O Mojiminiyi1, N Abdella2, M Kortom3, H Al Wazzan3

1 Department of Pathology, Faculty of Medicine, Kuwait University, Kuwait
2 Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait
3 Ministry of Health, Kuwait

Correspondence to:
Dr Rajaa Marouf
Kuwait University, PO Box 24923, Safat, Kuwait 13110; r-marouf{at}hsc.edu.kw Background: Proteinuria is a common manifestation of renal disease which is a significant cause of morbidity in patients with sickle cell disease (SCD).

Objective: To evaluate and compare cystatin C, ß2-microglobulin, and creatinine as markers of renal disease in relation to the degree of proteinuria and other complications of SCD.

Methods: 24 h urine collections were used for estimation of urine protein and creatinine clearance in 59 patients with SCD. Results were correlated with plasma cystatin C, ß2-microglobulin, creatinine, glomerular filtration rate (GFR; derived from plasma creatinine by Cockcroft-Gault, MDRD formulae, and calculated cystatin C clearance), and clinical and haematological variables.

Results: Comparing the different methods of GFR, the proportion of patients with hyperfiltration (GFR >140 ml/min) were 30.5% (MDRD), 44.1% (Cockcroft-Gault), and 10.2 % (calculated cystatin C clearance). Cystatin C was the most consistent marker of hyperfiltration. The endogenous markers of GFR showed an increasing trend with increasing proteinuria, but haematological variables were not correlated with cystatin C, ß2-microglobulin, or plasma creatinine. Urine protein excretion was correlated with age (r = 0.33) and significant proteinuria was present in 13.6% of patients. Patients with proteinuria had lower haemoglobin concentration (p = 0.027) than those without proteinuria but HbF was not related to the degree of proteinuria or to markers of GFR.

Conclusions: Markers of GFR show variable ability to identify hyperfiltration in patients with SCD, but cystatin C is the best endogenous marker. Proteinuria is associated with age, haemoglobin, and abnormalities of GFR. Routine screening is recommended to allow for early detection and intervention.


Abbreviations: GFR, glomerular filtration rate; MDRD, modification of diet in renal disease; SCD, sickle cell disease

Keywords: cystatin C; ß2-microglobulin; glomerular filtration rate; sickle cell disease







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.